Rise in the prevalence of cancer and chronic diseases, increase in the geriatric population, growth in the adoption of regenerative medicines, a surge in investments in R&D by pharmaceutical and biotechnology companies, rise in development & demand for monoclonal antibodies, increase in production of vaccines, and technological innovations in cell lines and the membrane fuel the growth of the global cell line and membrane market. However, a strict regulatory framework coupled with the time-consuming process for the development of stable lines might hinder the market growth. On the other hand, low-income countries lacking access to basic healthcare and an increase in the risk of pandemic and communicable diseases present new opportunities in the market in the coming years.
According to the report published by Allied Market Research, The Global Cell Line and Membrane Market Size was valued at USD 4.5 billion in 2021, and it is estimated to surpass around USD 10.6 billion by 2031, with a registered CAGR of 8.8% during 2021-2031.
Request a Sample Copy of the Report: https://www.alliedmarketresearch.com/request-sample/14227
Global Cell Line and Membrane Market Segmentation: –
Based on type, the recombinant cell lines segment was the largest market in 2021, accounting for more than one-third of the global cell line and membrane market, and is likely to lead the trail throughout the forecast period. This is due to the rise in the demand for recombinant cell line which owes greatly to technological advancements in expression vector design, cell line engineering, and clone screening. However, the primary cell lines segment is anticipated to manifest the fastest CAGR of 10.1% during the forecast period, owing to rise in adoption of primary cell line for the production and manufacturing of bio-therapeutics such as vaccines, monoclonal antibodies, and fusion proteins.
Based on products, the media and reagents segment contributed to the largest share of more than half of the global cell line and membrane market in 2021, and is expected to rule the roost during the forecast period. Moreover, the same segment is projected to witness the fastest CAGR of 9.2% from 2021 to 2031. The growth of this segment is attributed to rise in the prevalence of cancer and chronic diseases, rise in number of R&D activities globally, and increasing product approval and new product launches.
Based on source, the mammalian cell line segment held the largest share of more than two-thirds of the global cell line and membrane market in 2021, and is expected to maintain a prominent growth during the forecast period. The dominance of this segment can be attributed to the rise in the demand for recombinant protein development through mammalian cell. However, the non-mammalian cell line segment is likely to exhibit the highest CAGR of 9.8% in 2031, owing to the increase in adoption of regenerative medicines, rise in prevalence of cancer across the globe, and surge in investments in R&D by pharmaceutical and biotechnology companies.
Cell Line and Membrane Companies: –
- Advanced Instruments LLC
- AGC Biologics
- Cytiva Lifesciences
- Sartorius Cellgenix Gmbh
- Premas Biotech
- Selexis SA
- Lonza
- Samsung Biologics
- PromoCell
- Thermofisher Scientific Inc.
- Imegenex IndiaPvt. Ltd.
- ProBioGen
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/14227
By Region Outlook
North America
⦁ U.S.
⦁ Canada
⦁ Mexico
Europe
⦁ UK
⦁ Germany
⦁ France
⦁ Italy
⦁ Russia
⦁ Rest of Europe
Asia-Pacific
⦁ China
⦁ Japan
⦁ India
⦁ Australia
⦁ Rest of Asia-Pacific
LAMEA
⦁ Brazil
⦁ UAE
⦁ Turkey
⦁ Saudi Arabia
⦁ Rest of LAMEA
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in the coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2031?
- How big is the global & regional market in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- Which region has more opportunities?
Other Trending Report:
- Healthcare IT Market
- Rheumatoid Arthritis Drugs Market
- Proteomics Market
- Medical Device Affairs Outsourcing Market
Contact Details:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.